Responses
Poster Presentations
Psoriatic arthritis
SAT0448 Apremilast treatment and long-term (up to 156 weeks) improvements in dactylitis and enthesitis in patients with psoriatic arthritis: analysis of a large database of the phase iii clinical development program
Compose a Response to This Article
Other responses
No responses have been published for this article.